Financhill
Back

Royalty Pharma PLC Quote, Financials, Valuation and Earnings

Royalty Pharma PLC Price Quote

$24.97
+0.03 (+2.84%)
(Updated: December 21, 2024 at 5:45 AM ET)

Royalty Pharma PLC Key Stats

Sell
32
Royalty Pharma PLC (RPRX) is a Sell

Day range:
$24.32 - $25.00
52-week range:
$24.05 - $31.66
Dividend yield:
3.37%
P/E ratio:
9.86
P/S ratio:
6.56
P/B ratio:
1.61%

Volume:
6.9M
Avg. volume:
3.5M
1-year change:
-7.87%
Market cap:
$11.1B
Revenue:
$2.4B
EPS:
$2.55

How Much Does Royalty Pharma PLC Make?

Data Unavailable

Is Royalty Pharma PLC Growing As A Company?

Data Unavailable

Royalty Pharma PLC Stock Price Performance

What Is Royalty Pharma PLC 52-Week High & Low?

Royalty Pharma PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Royalty Pharma PLC?

Data Unavailable

Is Royalty Pharma PLC Cash Flow Positive?

Data Unavailable

Royalty Pharma PLC Return On Invested Capital

Data Unavailable

Royalty Pharma PLC Earnings Date & Stock Price

Royalty Pharma PLC Competitors

  • Who Are Royalty Pharma PLC's Competitors?
    Below is a list of companies who compete with Royalty Pharma PLC or are related in some way:
    • Arbutus Biopharma Corp (ABUS)
    • Amicus Therapeutics Inc (FOLD)
    • Geron Corp (GERN)
    • Ionis Pharmaceuticals Inc (IONS)
    • Regeneron Pharmaceuticals Inc (REGN)

Royalty Pharma PLC Dividend Yield

Data Unavailable

Royalty Pharma PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 656.25% 12.07%
Revenue: 5.29% -22.8%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable